Cargando…
A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy
Adalimumab is a recombinant monoclonal antibody to tumor necrosis factor alpha (TNFα) used in the treatment of inflammatory and autoimmune conditions, including ulcerative colitis (UC). Adverse side effects include infection and injection-site cutaneous reactions; however, rare adverse events such a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318094/ https://www.ncbi.nlm.nih.gov/pubmed/30648028 http://dx.doi.org/10.7759/cureus.3477 |
_version_ | 1783384813854523392 |
---|---|
author | Walsh, Leonard T Patel, Ravi Loloi, Justin Jones, Kirk Caler, Julie Ayaz, Zain Jain, Rohit |
author_facet | Walsh, Leonard T Patel, Ravi Loloi, Justin Jones, Kirk Caler, Julie Ayaz, Zain Jain, Rohit |
author_sort | Walsh, Leonard T |
collection | PubMed |
description | Adalimumab is a recombinant monoclonal antibody to tumor necrosis factor alpha (TNFα) used in the treatment of inflammatory and autoimmune conditions, including ulcerative colitis (UC). Adverse side effects include infection and injection-site cutaneous reactions; however, rare adverse events such as pancytopenia have been recorded. Here we describe a case of pancytopenia and reversible lymphadenopathy related to adalimumab administration in a patient with UC. |
format | Online Article Text |
id | pubmed-6318094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-63180942019-01-15 A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy Walsh, Leonard T Patel, Ravi Loloi, Justin Jones, Kirk Caler, Julie Ayaz, Zain Jain, Rohit Cureus Internal Medicine Adalimumab is a recombinant monoclonal antibody to tumor necrosis factor alpha (TNFα) used in the treatment of inflammatory and autoimmune conditions, including ulcerative colitis (UC). Adverse side effects include infection and injection-site cutaneous reactions; however, rare adverse events such as pancytopenia have been recorded. Here we describe a case of pancytopenia and reversible lymphadenopathy related to adalimumab administration in a patient with UC. Cureus 2018-10-22 /pmc/articles/PMC6318094/ /pubmed/30648028 http://dx.doi.org/10.7759/cureus.3477 Text en Copyright © 2018, Walsh et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Walsh, Leonard T Patel, Ravi Loloi, Justin Jones, Kirk Caler, Julie Ayaz, Zain Jain, Rohit A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title | A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title_full | A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title_fullStr | A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title_full_unstemmed | A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title_short | A Case of Adalimumab-associated Pancytopenia and Reversible Lymphadenopathy |
title_sort | case of adalimumab-associated pancytopenia and reversible lymphadenopathy |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318094/ https://www.ncbi.nlm.nih.gov/pubmed/30648028 http://dx.doi.org/10.7759/cureus.3477 |
work_keys_str_mv | AT walshleonardt acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT patelravi acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT loloijustin acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT joneskirk acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT calerjulie acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT ayazzain acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT jainrohit acaseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT walshleonardt caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT patelravi caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT loloijustin caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT joneskirk caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT calerjulie caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT ayazzain caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy AT jainrohit caseofadalimumabassociatedpancytopeniaandreversiblelymphadenopathy |